Erratum: Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells(Journal of Clinical Investigation(2016)126: (1()254–265)Doi:10.1172/JCI79775)

At the request of the corresponding author, the JCI is retracting this article. Following an institutional investigative review of errors in the article, it was determined that the data reported in Figure 1B were an analysis of E2F1 expression rather than CERS6 expression, as originally reported. The correct data do not show a difference in CERS6 expression with invasion status in human lung adenocarcinomas. In addition, errors were noted in Supplemental Figure 2, Supplemental Figure 3B, and Supplemental Table 1. The institutional review found no evidence of intention to falsify results.